45,000-Patient Registry Yields Atherothrombotic Disease Risk Factors
August 31, 2010 | Internal Medicine News
Author and Disclosure Information
From the annual congress of the European Society of Cardiology
“Our analysis provides simple criteria for assessing the risk of cardiovascular events in stable outpatients,” Dr. Bhatt said.
Concurrently with Dr. Bhatt’s report, the results were published online (JAMA 2010 Aug. 30 [doi: 10.1001/jama.2010.1322]). The REACH registry is partially sponsored by Sanofi-Aventis and Bristol-Myers Squibb. Dr. Bhatt reported receiving research grants from AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Heartscape, Sanofi-Aventis, and The Medicines Company.
